HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inga T Lennes Selected Research

Inga T Lennes Research Topics

Disease

17Neoplasms (Cancer)
01/2024 - 06/2011
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 06/2011
8Lung Neoplasms (Lung Cancer)
12/2022 - 02/2013
4Death (Near-Death Experience)
12/2015 - 06/2011
3COVID-19
01/2023 - 12/2020
1Edema (Dropsy)
07/2022
1Neoplasm Metastasis (Metastasis)
01/2022
1Pneumonia (Pneumonitis)
01/2021
1Mouth Neoplasms (Oral Cancer)
01/2020
1Breast Neoplasms (Breast Cancer)
02/2014
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2014

Drug/Important Bio-Agent (IBA)

3CrizotinibIBA
07/2022 - 01/2019
3ErbB Receptors (EGF Receptor)IBA
01/2018 - 01/2013
2Tyrosine Kinase InhibitorsIBA
12/2018 - 01/2013
1nirmatrelvirIBA
01/2023
1Peptide Hydrolases (Proteases)FDA Link
01/2023
1Ritonavir (Norvir)FDA Link
01/2023
1VaccinesIBA
01/2023
1Complement System Proteins (Complement)IBA
12/2022
1lorlatinibIBA
07/2022
1Oxygen (Dioxygen)IBA
01/2021
1capmatinibIBA
01/2021
1SolutionsIBA
12/2020
1Immune Checkpoint InhibitorsIBA
01/2019
1nazartinibIBA
01/2018
1Circulating Tumor DNAIBA
01/2018
1Indicators and Reagents (Reagents)IBA
12/2015
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2013
1erucylphosphocholineIBA
04/2012

Therapy/Procedure

12Drug Therapy (Chemotherapy)
01/2019 - 06/2011
10Therapeutics
01/2021 - 06/2011
6Palliative Care (Palliative Therapy)
01/2024 - 06/2011
3Terminal Care (Care, Terminal)
05/2015 - 02/2012
1Contraindications
01/2023
1Drug Tapering
07/2022
1Radiotherapy
01/2022
1Conservative Treatment
11/2021
1Aftercare (After-Treatment)
01/2018